Literature DB >> 9788132

MnDPDP enhancement characteristics and differentiation between cirrhotic and noncirrhotic livers.

L Martí-Bonmatí1, E Lonjedo, C Poyatos, C Casillas.   

Abstract

RATIONALE AND
OBJECTIVES: The objective was to analyze if liver enhancement with mangafodipir trisodium was influenced by liver cirrhosis.
METHODS: Eighty patients (49 with cirrhotic and 31 with noncirrhotic livers) were studied with spin-echo and spoiled gradient-echo T1-weighted images, before and after administration of mangafodipir trisodium. Hepatic insufficiency was assessed using the Child classification. Image analysis was performed both qualitatively and quantitatively.
RESULTS: Noncirrhotic livers enhanced homogeneously but 37% of cirrhotic livers did not; the difference was significant. Areas corresponding to collapsed fibrous zones enhanced less than the rest of the parenchyma; areas of regenerating nodular zones enhanced more. Signal-to-noise ratios were significantly less for cirrhotic livers on postcontrast spoiled gradient-echo images. Cirrhotic livers had significantly lower relative enhancement ratios than noncirrhotic ones. The Child index and aspartate aminotransferase values were statistically related to the enhancement ratio.
CONCLUSIONS: Mangafodipir trisodium enhancement in cirrhotic livers is related to necrosis and regeneration of the hepatocytes. Cirrhotic livers enhanced less than noncirrhotic ones.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9788132     DOI: 10.1097/00004424-199810000-00001

Source DB:  PubMed          Journal:  Invest Radiol        ISSN: 0020-9996            Impact factor:   6.016


  5 in total

Review 1.  Magnetic Resonance imaging analysis of liver fibrosis and inflammation: overwhelming gray zones restrict clinical use.

Authors:  D Marti-Aguado; A Rodríguez-Ortega; A Alberich-Bayarri; L Marti-Bonmati
Journal:  Abdom Radiol (NY)       Date:  2020-08-28

2.  Quantitative evaluation of hepatic fibrosis by fibro Scan and Gd-EOB-DTPA-enhanced T1 mapping magnetic resonance imaging in chronic hepatitis B.

Authors:  Qingtao Li; Tianyou Chen; Nannan Shi; Wen Ye; Min Yuan; Yuxin Shi
Journal:  Abdom Radiol (NY)       Date:  2021-11-25

3.  Safety and efficacy of Mangafodipir trisodium in patients with liver lesions and cirrhosis.

Authors:  Luis Martí-Bonmatí; Amura F Fog; Bart Op de Beeck; Pauline Kane; Hans Fagertun
Journal:  Eur Radiol       Date:  2002-12-19       Impact factor: 5.315

Review 4.  Hepatobiliary contrast agents for contrast-enhanced MRI of the liver: properties, clinical development and applications.

Authors:  Peter Reimer; Günter Schneider; Wolfgang Schima
Journal:  Eur Radiol       Date:  2004-02-25       Impact factor: 5.315

5.  MR imaging in liver cirrhosis: classical and new approaches.

Authors:  Luis Martí-Bonmatí; Fructuoso Delgado
Journal:  Insights Imaging       Date:  2010-08-05
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.